GlassScriptPhysician profile
Tabitha Davis Stellato
NPI 1093164295
$482.22
in general payments reported to CMS, 2019-2025
18 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $32.93 · 2023: $88.63 · 2024: $136 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $124.17 | 2023-2024 | |
| Novo Nordisk INC | $52.35 | 2025 | |
| Pfizer INC. | $47.58 | 2022-2023 | |
| Exact Sciences Corporation | $34.64 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $27.54 | 2023-2024 | Jardiance, Zepbound, Mounjaro |
| Seqirus USA INC | $20.45 | 2025 | Flucelvax, Fluad |
| Alkermes, INC. | $20.11 | 2025 | Vivitrol |
| Abbvie INC. | $19.80 | 2025 | |
| Scpharmaceuticals INC. | $17.82 | 2024 | |
| Xeris Pharmaceuticals, INC. | $17.05 | 2025 | Gvoke Hypopen |
| Amgen INC. | $15.95 | 2025 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $15.25 | 2023 | Arexvy, Bexsero, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $14.86 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $14.45 | 2022 | |
| Tactile Systems Technology INC | $14.25 | 2025 | Flexitouch Plus, Nimbl |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $11.18 | 2024 | Barostim Neo System |
| Phathom Pharmaceuticals, INC. | $7.60 | 2025 | Voquezna |
| Organon LLC | $7.17 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabitha Davis Stellato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.